KONSYL ORANGE SF OTC
Generic Name and Formulations:
Psyllium hydrophilic mucilloid 3.5g; per packet or rounded teaspoon; sugar-free pwd; contains phenylalanine.
Indications for KONSYL ORANGE SF:
Adults and Children:
Mix in 8oz liq, then drink 8oz more liq. <6yrs: not recommended. 6–12yrs: ½ adult dose. ≥12yrs: 1 packet or rounded teaspoonful (1 rounded tablespoonful for Konsyl Orange) 1–3 times daily.
Signs/symptoms of appendicitis. Intestinal obstruction. Fecal impaction.
Rectal bleeding. Diabetes (sugar-containing forms).
Tablets block tetracycline absorption (give at least 1hr before or 2hrs after tetracycline).
Esophageal, gastric, enteral, rectal obstruction.
Original—10.6oz, 15.9oz; Original packets—30; D—11.5oz, 17.5oz; Orange—19oz; Sugar-Free—10.6oz, 15.9oz; Sugar-Free packets—30; Sugar-Free Orange—15oz; Easy Mix—8.8oz (w. scoop); Tabs—90; Caps—100
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders